EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification of GALNT14 as a Key Regulator of Ferroptosis in Cisplatin-Induced Acute Kidney Injury: A Potential Target for Kidney Injury Treatment

Cheng Yuan, Yulu Ye, Yinjie Zhou, Lu Xu, Tingzhuang Yi, Lihua Ni

Kidney and Blood Pressure Research · 2025

DOI: 10.1159/000548252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2025. Verfasst von Cheng Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yichang Central People's Hospital and The First College of Clinical Medical Science, China Three Gorges University, Yichang, …. Hauptthemen laut MEDLINE: Ferroptosis, Cisplatin, Acute Kidney Injury, N-Acetylgalactosaminyltransferases. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cisplatin-induced acute kidney injury (Cis-AKI) is a significant cause of renal damage, characterized by tubular injury, ferroptosis, and oxidative stress. While therapeutic options for Cis-AKI remain limited, identifying novel targets to prevent kidney injury is critical. This study focuses on GALNT14, a gene associated with ferroptosis, and its potential role in mitigating Cis-AKI.

Methods

The Limma package was used to analyze differentially expressed genes (DEGs) between the saline and cisplatin groups. The weighted correlation network analysis (WGCNA) was performed to discover the co-expressed modules and hub genes linked with Cis-AKI. The hub genes were then put into String database to create a network of protein-protein interactions. The FerrDb database was used to acquire genes related to ferroptosis, which were then screened for their association with CiS-AKI. The role of GALNT14 was examined in vitro using HK-2 renal tubular cells and in vivo in a Cis-AKI murine model.

Results

Totally, 1,201 DEGs in intravenous (iv) administration group were retrieved. The 806 genes were obtained from intersection WGCNA and DEGs. Ultimately, we identified 4 genes (ALOX5, CD44, GALNT14, and ASNS) that may play important roles in the regulation of ferroptosis in Cis-AKI. The mRNA expression level of GALNT14 exhibited the most notable difference between Cis-AKI and the control group. In vitro, GALNT14 overexpression in HK-2 cells reduced renal injury and ferroptosis markers, including KIM1, NGAL, and FSP1, while increasing GPX4 expression. Conversely, silencing GALNT14 exacerbated Cis-AKI-induced injury. In vivo, GALNT14 overexpression in Cis-AKI mice attenuated kidney injury, reduced ferroptosis markers, and reversed pathological alterations such as tubular dilatation and loss of brush border.

Conclusion

GALNT14 inhibits Cis-AKI by regulating tubular ferroptosis, demonstrating its potential as a therapeutic target for kidney injury. Our findings suggest that GALNT14 could be an effective strategy for preventing Cis-AKI and improving renal function in kidney injury-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCisplatinAcute Kidney InjuryN-AcetylgalactosaminyltransferasesAnimalsMiceHumansCell LineMaleMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

Cisplatin-induced acute kidney injuryFerroptosisGALNT14

Substanzen

CisplatinN-AcetylgalactosaminyltransferasesUDP-N-acetyl-D-galactosamine polypeptide N-acetylgalactosaminyltransferase 14, human

Autor:innen und Institutionen

  • Department of Oncology, Yichang Central People's Hospital and The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
  • Tumor Prevention and Treatment Center of Three Gorges University and Cancer Research Institute of Three Gorges University, Yichang, China.
  • Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang, China.
  • Key Laboratory of Tumor Microenvironment and Immunotherapy of Hubei Province, Yichang, China.
  • Department of Oncology, Affiliated Hospital of YouJiang Medical University for Nationalities/Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Baise, China.
  • Department of Oncology, Yichang Central People's Hospital and The First College of Clinical Medical Science, China Three Gorges University, Yichang, China, xlnick@qq.com.

Zitieren

APA

Yuan, C., Ye, Y., Zhou, Y., Xu, L., Yi, T., & Ni, L. (2025). Identification of GALNT14 as a Key Regulator of Ferroptosis in Cisplatin-Induced Acute Kidney Injury: A Potential Target for Kidney Injury Treatment. Kidney and Blood Pressure Research. https://doi.org/10.1159/000548252

Vancouver

Yuan C, Ye Y, Zhou Y, Xu L, Yi T, Ni L. Identification of GALNT14 as a Key Regulator of Ferroptosis in Cisplatin-Induced Acute Kidney Injury: A Potential Target for Kidney Injury Treatment. Kidney and Blood Pressure Research. 2025. doi:10.1159/000548252

BibTeX
@article{Yuan2025,
  author = {Yuan, Cheng and Ye, Yulu and Zhou, Yinjie and Xu, Lu and Yi, Tingzhuang and Ni, Lihua},
  title = {Identification of GALNT14 as a Key Regulator of Ferroptosis in Cisplatin-Induced Acute Kidney Injury: A Potential Target for Kidney Injury Treatment},
  journal = {Kidney and Blood Pressure Research},
  year = {2025},
  doi = {10.1159/000548252}
}
Kostenlos starten →